Published in Sleep on October 01, 2011
Restless nocturnal eating: a common feature of Willis-Ekbom Syndrome (RLS). J Clin Sleep Med (2012) 0.86
Challenges in the development of therapeutics for narcolepsy. Prog Neurobiol (2015) 0.79
Reward-based behaviors and emotional processing in human with narcolepsy-cataplexy. Front Behav Neurosci (2013) 0.77
Rapid eye movement sleep behavior disorder in adults younger than 50 years of age. Sleep Med (2013) 0.76
The far side of sleep: Towards a deeper understanding of parasomnias and nocturnal seizures. Sleep Sci (2014) 0.75
Parasomnias. CMAJ (2014) 0.75
An inventory for measuring depression. Arch Gen Psychiatry (1961) 84.61
A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep (1991) 44.17
Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health. Sleep Med (2003) 12.71
Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell (1998) 12.66
Neurons containing hypocretin (orexin) project to multiple neuronal systems. J Neurosci (1998) 9.88
The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity. Proc Natl Acad Sci U S A (1998) 9.32
Reduced number of hypocretin neurons in human narcolepsy. Neuron (2000) 6.94
Practice parameters for clinical use of the multiple sleep latency test and the maintenance of wakefulness test. Sleep (2005) 5.66
Validation of the International Restless Legs Syndrome Study Group rating scale for restless legs syndrome. Sleep Med (2003) 4.95
The sleep switch: hypothalamic control of sleep and wakefulness. Trends Neurosci (2001) 4.33
Chemically defined projections linking the mediobasal hypothalamus and the lateral hypothalamic area. J Comp Neurol (1998) 3.01
Self-administered nicotine activates the mesolimbic dopamine system through the ventral tegmental area. Brain Res (1994) 2.95
To eat or to sleep? Orexin in the regulation of feeding and wakefulness. Annu Rev Neurosci (2001) 2.84
Distribution of orexin neurons in the adult rat brain. Brain Res (1999) 2.60
Afferents to the orexin neurons of the rat brain. J Comp Neurol (2006) 2.57
Orexins, orexigenic hypothalamic peptides, interact with autonomic, neuroendocrine and neuroregulatory systems. Proc Natl Acad Sci U S A (1999) 2.39
Nocturnal eating: sleep-related eating disorder or night eating syndrome? A videopolysomnographic study. Sleep (2006) 2.35
Orexin/hypocretin: a neuropeptide at the interface of sleep, energy homeostasis, and reward system. Pharmacol Rev (2009) 2.02
Obsessional-compulsive complaints. Behav Res Ther (1977) 1.92
Increased body-mass index in patients with narcolepsy. Lancet (2000) 1.78
Association of restless legs syndrome with nocturnal eating: a case-control study. Mov Disord (2009) 1.70
Clinical aspects of narcolepsy-cataplexy across ethnic groups. Sleep (2002) 1.59
Sleep-related eating disorders: polysomnographic correlates of a heterogeneous syndrome distinct from daytime eating disorders. Sleep (1991) 1.46
Clinical and polysomnographic features of sleep-related eating disorder. J Clin Psychiatry (1998) 1.37
Increased prevalence of obesity in narcoleptic patients and relatives. Eur Arch Psychiatry Clin Neurosci (2001) 1.36
Hypocretins regulate the anxiogenic-like effects of nicotine and induce reinstatement of nicotine-seeking behavior. J Neurosci (2010) 1.21
Health-related quality of life in narcolepsy. J Sleep Res (2001) 1.18
Body mass index-independent metabolic alterations in narcolepsy with cataplexy. Sleep (2009) 1.13
Eating disorder and metabolism in narcoleptic patients. Sleep (2007) 1.11
Review of nocturnal sleep-related eating disorders. Int J Eat Disord (1994) 1.09
Increased prevalence of nocturnal smoking in restless legs syndrome (RLS). Sleep Med (2010) 1.09
A pilot double-blind placebo-controlled trial of low-dose pramipexole in sleep-related eating disorder. Eur J Neurol (2005) 1.08
Nocturnal eating syndrome in adults. Sleep (1994) 1.08
Additional categories of sleep-related eating disorders and the current status of treatment. Sleep (1993) 1.03
Characteristics of narcolepsy in preteenaged children. Pediatrics (1990) 1.01
A putative link between childhood narcolepsy and obesity. Sleep Med (2004) 1.01
Psychological health in central hypersomnias: the French Harmony study. J Neurol Neurosurg Psychiatry (2009) 0.97
A 5-year prospective cohort study on health-related quality of life in patients with narcolepsy. Sleep Med (2010) 0.95
High prevalence of eating disorders in narcolepsy with cataplexy: a case-control study. Sleep (2008) 0.95
Narcolepsy in children. Sleep (1994) 0.90
Restless legs syndrome is frequent in narcolepsy with cataplexy patients. Sleep (2010) 0.89
Modafinil decreases food intake in humans subjected to simulated shift work. Pharmacol Biochem Behav (2008) 0.86
Depresssion in narcolepsy and hypersommia. Schweiz Arch Neurol Neurochir Psychiatr (1975) 0.83
Transforming between Beck Depression Inventory and CORE-OM scores in routine clinical practice. Br J Clin Psychol (2006) 0.83
Venlafaxine treatment of binge-eating disorder associated with obesity: a series of 35 patients. J Clin Psychiatry (2002) 0.82
Narcoleptic patients' perceptions of nicotine. J Clin Sleep Med (2009) 0.81
The Maudsley Obsessional-Compulsive Inventory and OCD in a Norwegian nonclinical sample. Scand J Psychol (2000) 0.79
Sodium oxybate in the treatment of binge eating disorder: an open-label, prospective study. Int J Eat Disord (2011) 0.79
The Maudsley Obsessional-Compulsive Inventory: a psychometric investigation on Chinese normal subjects. Behav Res Ther (1990) 0.76
Short sleep duration is associated with reduced leptin, elevated ghrelin, and increased body mass index. PLoS Med (2004) 11.17
Narcolepsy with cataplexy. Lancet (2007) 4.81
History of the development of sleep medicine in the United States. J Clin Sleep Med (2005) 4.22
Narcolepsy onset is seasonal and increased following the 2009 H1N1 pandemic in China. Ann Neurol (2011) 4.09
The endogenous cannabinoid system affects energy balance via central orexigenic drive and peripheral lipogenesis. J Clin Invest (2003) 3.62
OPA1 mutations induce mitochondrial DNA instability and optic atrophy 'plus' phenotypes. Brain (2007) 3.35
Narcolepsy is strongly associated with the T-cell receptor alpha locus. Nat Genet (2009) 3.33
Post-H1N1 narcolepsy-cataplexy. Sleep (2010) 3.10
Elevated anti-streptococcal antibodies in patients with recent narcolepsy onset. Sleep (2009) 3.06
Kleine-Levin syndrome: a systematic study of 108 patients. Ann Neurol (2008) 3.03
Missense mutations in the sodium-gated potassium channel gene KCNT1 cause severe autosomal dominant nocturnal frontal lobe epilepsy. Nat Genet (2012) 2.98
Regulation, function, and dysregulation of endocannabinoids in models of adipose and beta-pancreatic cells and in obesity and hyperglycemia. J Clin Endocrinol Metab (2006) 2.72
Mapping multiple sclerosis susceptibility to the HLA-DR locus in African Americans. Am J Hum Genet (2003) 2.71
Retracted CD4+ T cell autoimmunity to hypocretin/orexin and cross-reactivity to a 2009 H1N1 influenza A epitope in narcolepsy. Sci Transl Med (2013) 2.51
Nocturnal eating: sleep-related eating disorder or night eating syndrome? A videopolysomnographic study. Sleep (2006) 2.35
Characterization of sleep in zebrafish and insomnia in hypocretin receptor mutants. PLoS Biol (2007) 2.34
The role of hypocretins (orexins) in sleep regulation and narcolepsy. Annu Rev Neurosci (2002) 2.28
Genetics of sleep and sleep disorders. Cell (2011) 2.26
Sympathetic skin response: basic mechanisms and clinical applications. Clin Auton Res (2003) 2.24
New approaches to the study of periodic leg movements during sleep in restless legs syndrome. Sleep (2006) 2.24
Cyclic alternating pattern in sleep and its relationship to creativity. Sleep Med (2011) 2.21
Variant between CPT1B and CHKB associated with susceptibility to narcolepsy. Nat Genet (2008) 2.09
Pharmacological management of obesity: an endocrine Society clinical practice guideline. J Clin Endocrinol Metab (2015) 2.05
Retinal nerve fiber layer evaluation by optical coherence tomography in unaffected carriers with Leber's hereditary optic neuropathy mutations. Ophthalmology (2005) 2.01
Movement disorders in sleep: guidelines for differentiating epileptic from non-epileptic motor phenomena arising from sleep. Sleep Med Rev (2007) 2.00
Violence in sleep. Brain (2010) 1.92
Retinal nerve fiber layer evaluation by optical coherence tomography in Leber's hereditary optic neuropathy. Ophthalmology (2005) 1.88
Correlates of serum C-reactive protein (CRP)--no association with sleep duration or sleep disordered breathing. Sleep (2007) 1.88
Alcohol-induced sleepwalking or confusional arousal as a defense to criminal behavior: a review of scientific evidence, methods and forensic considerations. J Sleep Res (2007) 1.87
DQB1*0602 predicts interindividual differences in physiologic sleep, sleepiness, and fatigue. Neurology (2010) 1.86
Efficacy of rotigotine for treatment of moderate-to-severe restless legs syndrome: a randomised, double-blind, placebo-controlled trial. Lancet Neurol (2008) 1.83
Diagnosis, disease course, and management of patients with Kleine-Levin syndrome. Lancet Neurol (2012) 1.83
Plasma adiponectin in nonalcoholic fatty liver is related to hepatic insulin resistance and hepatic fat content, not to liver disease severity. J Clin Endocrinol Metab (2005) 1.73
The narcoleptic borderland: a multimodal diagnostic approach including cerebrospinal fluid levels of hypocretin-1 (orexin A). Sleep Med (2003) 1.72
Association of restless legs syndrome with nocturnal eating: a case-control study. Mov Disord (2009) 1.70
Diffusion-weighted brain imaging study of patients with clinical diagnosis of corticobasal degeneration, progressive supranuclear palsy and Parkinson's disease. Brain (2008) 1.69
A link between short sleep and obesity: building the evidence for causation. Sleep (2005) 1.67
Insights from studying human sleep disorders. Nature (2005) 1.66
Common variants in P2RY11 are associated with narcolepsy. Nat Genet (2010) 1.65
Clinical and therapeutic aspects of childhood narcolepsy-cataplexy: a retrospective study of 51 children. Sleep (2010) 1.64
Circadian and homeostatic regulation of hypocretin in a primate model: implications for the consolidation of wakefulness. J Neurosci (2003) 1.64
The circadian rhythm of body core temperature (CRT) is normal in patient with congenital generalized anhidrosis. Clin Auton Res (2002) 1.64
Killer cell immunoglobulin-like receptor genotype and killer cell immunoglobulin-like receptor-human leukocyte antigen C ligand compatibility affect the severity of hepatitis C virus recurrence after liver transplantation. Liver Transpl (2009) 1.60
Sleep-dependent changes in the coupling between heart period and blood pressure in human subjects. Am J Physiol Regul Integr Comp Physiol (2008) 1.59
Clinical aspects of narcolepsy-cataplexy across ethnic groups. Sleep (2002) 1.59
ImmunoChip study implicates antigen presentation to T cells in narcolepsy. PLoS Genet (2013) 1.55
PER3 polymorphism predicts cumulative sleep homeostatic but not neurobehavioral changes to chronic partial sleep deprivation. PLoS One (2009) 1.54
The hypothalamic-pituitary-adrenal axis activity in obesity and the metabolic syndrome. Ann N Y Acad Sci (2006) 1.53
Physiologic autonomic arousal heralds motor manifestations of seizures in nocturnal frontal lobe epilepsy: implications for pathophysiology. Sleep Med (2012) 1.51
Mutations in DNMT1 cause autosomal dominant cerebellar ataxia, deafness and narcolepsy. Hum Mol Genet (2012) 1.48
Human leukocyte antigen crossmatch testing is important for liver retransplantation. Liver Transpl (2010) 1.48
Solid-papillary tumors of the pancreas: histopathology. JOP (2006) 1.47
Anti-Tribbles homolog 2 (TRIB2) autoantibodies in narcolepsy are associated with recent onset of cataplexy. Sleep (2010) 1.47
The burden of narcolepsy with cataplexy: how disease history and clinical features influence socio-economic outcomes. Sleep Med (2012) 1.46
Homozygous PINK1 C-terminus mutation causing early-onset parkinsonism. Ann Neurol (2004) 1.44
Slow eye movements distribution during nocturnal sleep. Clin Neurophysiol (2011) 1.41
Proposed diagnostic criteria for night eating syndrome. Int J Eat Disord (2010) 1.41
The incidence of narcolepsy in Europe: before, during, and after the influenza A(H1N1)pdm09 pandemic and vaccination campaigns. Vaccine (2012) 1.41
Human leukocyte antigen polymorphisms in Italian primary biliary cirrhosis: a multicenter study of 664 patients and 1992 healthy controls. Hepatology (2008) 1.40
Idebenone treatment in Leber's hereditary optic neuropathy. Brain (2011) 1.39
Insomnia cycling with a 42-day infradian period: evidence for two uncoupled circadian oscillators? Sleep Med (2010) 1.38
Complex movement disorders at disease onset in childhood narcolepsy with cataplexy. Brain (2011) 1.35
CB(1) signaling in forebrain and sympathetic neurons is a key determinant of endocannabinoid actions on energy balance. Cell Metab (2010) 1.33
Circadian and homeostatic regulation of structural synaptic plasticity in hypocretin neurons. Neuron (2010) 1.33
Treatment of restless legs syndrome: an evidence-based review and implications for clinical practice. Mov Disord (2008) 1.33
A quantitative statistical analysis of the submentalis muscle EMG amplitude during sleep in normal controls and patients with REM sleep behavior disorder. J Sleep Res (2008) 1.33
Sleep/wake fragmentation disrupts metabolism in a mouse model of narcolepsy. J Physiol (2007) 1.30
Epitopes of human leukocyte antigen class I antibodies found in sera of normal healthy males and cord blood. Hum Immunol (2009) 1.29
Effect of flutamide and metformin administered alone or in combination in dieting obese women with polycystic ovary syndrome. Clin Endocrinol (Oxf) (2004) 1.29
Relationship between CSF hypocretin levels and hypocretin neuronal loss. Exp Neurol (2003) 1.28
Predictors of hypocretin (orexin) deficiency in narcolepsy without cataplexy. Sleep (2012) 1.28